Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
News
Gastroenterology
2 Nov 2024
Rifaximin Beats Lactulose in Preventing Hepatic Encephalopathy Recurrence: ACG 2024
Research presented at the American College of Gastroenterology (ACG) 2024 Annual Meeting showed that rifaximin monotherapy significantly reduces the risk of recurring overt hepatic encephalopathy
Gastroenterology
2 Nov 2024
GLP-1 Drugs for Type 2 Diabetes Reduce Pancreatic Cancer Risk: ACG 2024
New research presented at the American College of Gastroenterology (ACG) Annual Meeting suggests that GLP-1 receptor agonists (GLP-1RAs) may significantly lower the risk of pancreatic cancer in patients with type 2 diabetes
Dermatology
2 Nov 2024
Warning Issued as Scabies Cases Surge Across England
The Royal College of General Practitioners (RCGP) has reported a significant rise in scabies cases presenting at GP surgeries across England…
Cardiology
1 Nov 2024
Long-Term Effects of Recurrent Rejection on Paediatric Heart Transplant Outcomes
Analysis of recurrent rejection (RR) in paediatric heart transplant recipients revealed that 17% of the population studied experienced RR.
Urology
1 Nov 2024
24-Hour Antibiotic Course Prevents Infection Post-Cystectomy
A recent single-centre, randomised, trial has explored the effects of a 24-hour perioperative antibiotic course for patients undergoing cystectomy.
Respiratory
1 Nov 2024
Air Pollution's Role in Rising Global Asthma Cases
Recent studies and meta-analyses have investigated the impact of PM2.5 on asthma, yet findings remain inconsistent.
Radiology
1 Nov 2024
AI Model Matches Radiologists in Detecting Chest X-Ray Abnormalities
A commercially available AI model has been found to perform on par with radiologists in detecting chest X-ray abnormalities.
Neurology
1 Nov 2024
Semaglutide Reduces Risk of Alzheimer’s Disease
Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in people with Type 2 diabetes (T2D).
Loading posts...
« Previous
1
…
20
21
22
23
24
…
419
Next »